Nivolumab plus Carboplatin and Paclitaxel as the First-line Therapy for Advanced Squamous Cell Carcinoma of the Lung with Strong Programmed Death-ligand 1 Expression: A Case Report

An 80-year-old male patient was diagnosed to have squamous cell carcinoma of the lung which had a high level of programmed death-ligand 1 (PD-L1) expression. He was prescribed with intravenously administered nivolumab combined with carboplatin and paclitaxel as the first-line therapy. A rapid remiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Frank S, Yang, Chung-Fan, Chang, Chia-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837275/
https://www.ncbi.nlm.nih.gov/pubmed/31772851
http://dx.doi.org/10.7759/cureus.5881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837275/
https://www.ncbi.nlm.nih.gov/pubmed/31772851
http://dx.doi.org/10.7759/cureus.5881

Ejemplares similares